Clinical Trial

Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Interventions of both groups: Oxygenated gel Group: 15 patients who used oxygenated gel (Blue®m, Wijhe, Netherlands) were trained by the co-investigator (A.H) through real demonstration for topical application of the gel on aphthous ulcers, which entails the application of 1-2 ml of oxygenated gel directly to the ulcer two times per day and this was repeated for 7 days. Triamcinolone acetonide Group: 15 patients were treated with Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g), four times (i.e., at 8 am, 12 noon, 4 pm, and 8 pm) a day for 7 days at intervention group. Patients in both groups were reexamined after treatment at different intervals (day 3, day 5, day 7, and day 10).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-28; most recent amendment 2025-09-16.
Trial Details
NCT Number NCT06910579
Lead Sponsor British University In Egypt
Conditions Aphthus Ulcer
Enrollment 30 participants
Start Date 2025-03-15
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-04-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-18